Each filer's latest filing for 21833P301 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
RA Capital Management, L.P.
13G
|
9.9% |
9/30/2026
Event 9/23/2026
|
||
| RA Capital Management, L.P. | 9.9% | |||
| Peter Kolchinsky | 9.9% | |||
| Rajeev Shah | 9.9% | |||
| RA Capital Healthcare Fund, L.P. | 9.9% | |||
| MPM BioImpact LLC 13G | 8.6% |
11/13/2026
Event 9/30/2026
|
||
|
Cormorant Asset Management, LP
13G/A
|
7.8% |
11/2/2026
Event 10/31/2026
|
||
| Cormorant Asset Management, LP | 7.8% | |||
| Chen Bihua | 7.8% | |||
| BlackRock, Inc. 13G | 5.9% |
7/27/2026
Event 6/30/2026
|
||
|
OrbiMed Advisors LLC
13G/A
|
5.9% |
2/14/2025
Event 12/31/2024
|
||
| OrbiMed Advisors LLC | 3.7% | |||
| OrbiMed Capital LLC | 5.9% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
| Vanguard Group Inc 13G/A | 4.9% |
7/29/2025
Event 6/30/2025
|
||
|
Citadel Advisors LLC
13G/A
|
1.1% |
8/14/2026
Event 6/30/2026
|
||
| Citadel Advisors LLC | 0% | |||
| Citadel Advisors Holdings LP | 0% | |||
| Citadel GP LLC | 0% | |||
| Citadel Securities LLC | 1.1% | |||
| Citadel Securities Group LP | 1.1% | |||
| Citadel Securities GP LLC | 1.1% | |||
| Kenneth Griffin | 1.1% | |||
|
Aberdeen Group plc
13G/A
|
0% |
10/29/2026
Event 9/16/2026
|
||
| Aberdeen Group plc | 0% | |||
| abrdn Inc. | 0% | |||
|
Octagon Capital Advisors LP
13G/A
|
0% |
5/14/2026
Event 3/31/2026
|
||
| Octagon Capital Advisors LP | 0% | |||
| Octagon Investments Master Fund LP | 0% | |||
| Ting Jia | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 124 | 17.6 M | $120M |
| 2026 Q2 | 107 | 13.8 M | $129M |
| 2026 Q1 | 108 | 12.9 M | $121M |
| 2025 Q4 | 102 | 13.3 M | $108M |
| 2025 Q3 | 88 | 8.80 M | $109M |
| 2025 Q2 | 83 | 9.07 M | $62.5M |
| 2025 Q1 | 88 | 10.4 M | $55.4M |
| 2024 Q4 | 101 | 11.0 M | $129M |
| 2024 Q3 | 112 | 11.8 M | $243M |
| 2024 Q2 | 108 | 10.8 M | $486M |
| 2024 Q1 | 85 | 8.53 M | $335M |
| 2023 Q4 | 36 | 750 k | $4.53M |
| 2023 Q3 | 29 | 743 k | $5.00M |
| 2023 Q2 | 30 | 739 k | $5.80M |
| 2023 Q1 | 31 | 724 k | $5.26M |
| 2020 Q1 | 1 | 1.00 k | $5.24k |
| 2019 Q4 | 1 | 1.00 k | $5.46k |